Do you want to read an article? Please log in or register.
Improvement in Serum Eosinophilia is Observed in Clinical Responders to Ustekinumab but not Adalimumab in Inflammatory Bowel Disease
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease
Inflamm Bowel Dis
Dulai PS, Johnson E, Cox K, Eldasher LM, Theriault N
doi: 10.1093/ibd/izae270
RECOMMENDED
Inflammatory Bowel Disease
Incidence, disease burden and clinical presentation of patients newly diagnosed with inflammatory bowel disease in a population-based inception cohort
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Attauabi M, Madsen GR, Bendtsen F, Seidelin JB, Burisch J
doi: 10.1093/ecco-jcc/jjae176
Inflammatory Bowel Disease
Corticosteroid Use in Randomized Clinical Trials of Biologics and Small Molecules in Inflammatory Bowel Disease: A Systematic Review
Inflamm Bowel Dis
da Silva BC, Papasotiriou S, Hanauer SB
doi: 10.1093/ibd/izae240
Inflammatory Bowel Disease
Distribution of Serum Testosterone Concentrations in IBD Males and Associations With Inflammatory Bowel Disease Activity
Inflamm Bowel Dis
Judge C, Lightowler D, Singh A, Yeap BB, Thin L
doi: 10.1093/ibd/izae177
Inflammatory Bowel Disease
Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study
Inflamm Bowel Dis
Petrov JC, Desai AA, Kochhar GS, Crosby SK, Kinnucan JA, Picco MF, Hashash JG, Farraye FA
doi: 10.1093/ibd/izae147
Inflammatory Bowel Disease
Clinical outcomes after first-line anti-TNF treatment of patients with inflammatory bowel disease - a prospective multicenter cohort study
J Crohns Colitis
Zhao M, Larsen L, Dige A, Poulsen A, Lo B, Attauabi M, Dige Ovesen P, Wewer MD, Christiansen D, Hvas CL, Petersen AM, Bendtsen F, Seidelin J, Burisch J
doi: 10.1093/ecco-jcc/jjae192
RECOMMENDED
Inflammatory Bowel Disease
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology
Hanžel J, Solitano V, Vuyyuru SK, Panaccione R, Sands BE, Peyrin-Biroulet L, Danese S, D'Haens GR, Atreya R, Allez M, Bernstein CN, Bossuyt P, Bressler B, Bryant RV, Cohen BL, Colombel JF, D'Amico F, Dignass A, Dubinsky M, Fleshner P, Gearry RB, Hanauer SB, Hart AL, Kayal M, Kucharzik T, Lakatos PL, Louis E, Magro F, Narula N, Leong RW, Panés J, Raine T, Ran Z, Regueiro MD, Reinisch W, Singh S, Steinhart AH, Travis S, Ungaro RC, Janneke van der Woude C, Yamamoto T, Ahuja V, Rubin DT, Dulai PS, Cornfield LJ, Hogan M, Sandborn WJ, Feagan BG, Jairath V, Ma C
doi: 10.1053/j.gastro.2025.05.015
Inflammatory Bowel Disease
Food Compounds Associated With Disease Activity in Inflammatory Bowel Disease
Inflamm Bowel Dis
Meima M, Westerhout J, Meijerink M, Bijlsma S, van Schaik F, Oldenburg B, Houben G
doi: 10.1093/ibd/izaf126
Inflammatory Bowel Disease
Assessment and Reporting of Extraintestinal Manifestations and Fatigue in Phase 3 Inflammatory Bowel Disease Clinical Trials
J Crohns Colitis
Chhibba T, Sachdeva K, Ananthakrishnan AN
doi: 10.1093/ecco-jcc/jjaf009